Voriconazole

This classification denotes an antifungal agent with the molecular formula C16H14F3N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JFU09I87TR, chemically known as 4-pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1h-1,2,4-triazol-1-ylmethyl)-, (r-(r*,s*))- but generally known as voriconazole, which bears US NIH Compound Identifier 71616. European Medicines Agency schedules Voriconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00087MIG. The term VORICONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). World Health Organization schedules voriconazole in its Anatomical Therapeutic Chemical (ATC) Classification. VORICONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule voriconazole under HS 29335995 and SITC 51576. As of Q4 2014, VORICONAZOLE remains the US FDA Preferred Term for this commodity. Voriconazole bears US NLM identifiers UMLS ID C0393080 and NCI Concept Code C1707. SMILES: FC1C(C(O)(C(C)C2NCNCC2F)CN2NCNC2)CCC(F)C1.